Sade Group

Cannabis-based Pharmaceutical Products

Health Tech & Life Sciences
Private

Company Overview

Snapshot

Founded in December 2015, Sade Group operates with 1–10 employees. The company has completed one funding round. In May 2019, Ori Yehudai joined Sade Group as an active Chairman.

Business overview

Sade Group is a Health Tech & Life Sciences company focused on cannabis-based pharmaceutical products. The company developed ASAYA, a platform that optimizes clinical outcomes for medical cannabis treatment by leveraging big data analysis and expert-based algorithms. ASAYA integrates real-world practice and patient-reported outcomes with human and machine intelligence, utilizing machine learning, IoT, mobile applications, and predictive analytics to provide practical guidance for medical cannabis use. Sade Group serves the medical cannabis ecosystem, including healthcare professionals, patients, growers, and researchers.

Strategic signal

In July 2019, Ori Yehudai departed Sade Group just two months after joining as an active Chairman. This swift exit, following his high-profile entry in May 2019 after the sale of Frutarom, suggests a potential shift in leadership or strategic direction for the company, indicating a period of adjustment for investors and stakeholders.

Company Intelligence Q&A

What is Sade Group's primary focus?
Sade Group specializes in cannabis-based pharmaceutical products, developing solutions to optimize clinical outcomes for medical cannabis treatment.
What is ASAYA?
ASAYA is Sade Group's platform designed to optimize clinical outcomes for medical cannabis treatment through big data analysis and algorithms based on expert best practices. It integrates real-world practice and patient-reported outcomes with human and machine intelligence.
Which technologies does ASAYA utilize?
ASAYA leverages cutting-edge technologies including machine learning, IoT, mobile applications, and predictive analytics to enhance medical cannabis care.
Who are the target beneficiaries of Sade Group's technology?
Sade Group's technology aims to benefit the entire medical cannabis ecosystem, including healthcare professionals, patients, growers, and researchers.
What significant leadership change occurred at Sade Group in 2019?
In July 2019, Ori Yehudai resigned from Sade Group, only two months after joining the company as an active Chairman in May 2019.